nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A8—Mercaptopurine—Crohn's disease	0.479	1	CbGbCtD
Cefotaxime—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0185	0.0923	CbGpPWpGaD
Cefotaxime—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0185	0.0923	CbGpPWpGaD
Cefotaxime—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0168	0.0838	CbGpPWpGaD
Cefotaxime—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0168	0.0838	CbGpPWpGaD
Cefotaxime—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0141	0.0704	CbGpPWpGaD
Cefotaxime—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0141	0.0704	CbGpPWpGaD
Cefotaxime—Cholestasis—Mercaptopurine—Crohn's disease	0.012	0.0412	CcSEcCtD
Cefotaxime—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0118	0.0588	CbGpPWpGaD
Cefotaxime—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0118	0.0588	CbGpPWpGaD
Cefotaxime—Liver injury—Mercaptopurine—Crohn's disease	0.0108	0.0372	CcSEcCtD
Cefotaxime—Local reaction—Mesalazine—Crohn's disease	0.00893	0.0307	CcSEcCtD
Cefotaxime—Candida infection—Mercaptopurine—Crohn's disease	0.00869	0.0299	CcSEcCtD
Cefotaxime—Nephropathy toxic—Mesalazine—Crohn's disease	0.0086	0.0296	CcSEcCtD
Cefotaxime—Nephritis interstitial—Mesalazine—Crohn's disease	0.00732	0.0252	CcSEcCtD
Cefotaxime—Cholestasis—Azathioprine—Crohn's disease	0.00714	0.0246	CcSEcCtD
Cefotaxime—Cholestasis—Mesalazine—Crohn's disease	0.00651	0.0224	CcSEcCtD
Cefotaxime—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.00645	0.0222	CcSEcCtD
Cefotaxime—Liver injury—Azathioprine—Crohn's disease	0.00645	0.0222	CcSEcCtD
Cefotaxime—Liver injury—Mesalazine—Crohn's disease	0.00587	0.0202	CcSEcCtD
Cefotaxime—Tenderness—Mesalazine—Crohn's disease	0.00566	0.0195	CcSEcCtD
Cefotaxime—Colitis—Azathioprine—Crohn's disease	0.00521	0.0179	CcSEcCtD
Cefotaxime—Aplastic anaemia—Azathioprine—Crohn's disease	0.00509	0.0175	CcSEcCtD
Cefotaxime—Vaginal inflammation—Mesalazine—Crohn's disease	0.00494	0.017	CcSEcCtD
Cefotaxime—Colitis—Mesalazine—Crohn's disease	0.00474	0.0163	CcSEcCtD
Cefotaxime—Candida infection—Mesalazine—Crohn's disease	0.00472	0.0162	CcSEcCtD
Cefotaxime—Vaginal infection—Mesalazine—Crohn's disease	0.00467	0.016	CcSEcCtD
Cefotaxime—Aplastic anaemia—Mesalazine—Crohn's disease	0.00464	0.0159	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00451	0.0155	CcSEcCtD
Cefotaxime—Renal impairment—Mesalazine—Crohn's disease	0.00377	0.013	CcSEcCtD
Cefotaxime—Dermatitis bullous—Mesalazine—Crohn's disease	0.00375	0.0129	CcSEcCtD
Cefotaxime—Cephaloglycin—SLC22A5—Crohn's disease	0.00371	0.127	CrCbGaD
Cefotaxime—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00371	0.0185	CbGpPWpGaD
Cefotaxime—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00371	0.0185	CbGpPWpGaD
Cefotaxime—Leukopenia—Mercaptopurine—Crohn's disease	0.00356	0.0122	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00355	0.0122	CcSEcCtD
Cefotaxime—Cefepime—SLC22A5—Crohn's disease	0.00351	0.12	CrCbGaD
Cefotaxime—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00336	0.0168	CbGpPWpGaD
Cefotaxime—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00336	0.0168	CbGpPWpGaD
Cefotaxime—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00318	0.0109	CcSEcCtD
Cefotaxime—Eosinophilia—Mesalazine—Crohn's disease	0.00307	0.0106	CcSEcCtD
Cefotaxime—Bronchospasm—Mesalazine—Crohn's disease	0.00305	0.0105	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00301	0.0103	CcSEcCtD
Cefotaxime—Neutropenia—Mesalazine—Crohn's disease	0.0029	0.00996	CcSEcCtD
Cefotaxime—Agranulocytosis—Azathioprine—Crohn's disease	0.00283	0.00973	CcSEcCtD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00283	0.0141	CbGpPWpGaD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00283	0.0141	CbGpPWpGaD
Cefotaxime—Cefixime—SLC22A5—Crohn's disease	0.00275	0.0939	CrCbGaD
Cefotaxime—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00274	0.00942	CcSEcCtD
Cefotaxime—Haemoglobin—Azathioprine—Crohn's disease	0.00274	0.00941	CcSEcCtD
Cefotaxime—Haemorrhage—Azathioprine—Crohn's disease	0.00272	0.00936	CcSEcCtD
Cefotaxime—Renal failure—Mesalazine—Crohn's disease	0.00272	0.00934	CcSEcCtD
Cefotaxime—Jaundice—Mesalazine—Crohn's disease	0.00269	0.00926	CcSEcCtD
Cefotaxime—Ceftazidime—SLC22A5—Crohn's disease	0.00259	0.0883	CrCbGaD
Cefotaxime—Agranulocytosis—Mesalazine—Crohn's disease	0.00258	0.00887	CcSEcCtD
Cefotaxime—Erythema multiforme—Azathioprine—Crohn's disease	0.00258	0.00885	CcSEcCtD
Cefotaxime—Body temperature increased—Mercaptopurine—Crohn's disease	0.00257	0.00883	CcSEcCtD
Cefotaxime—Cefdinir—SLC22A5—Crohn's disease	0.00254	0.0867	CrCbGaD
Cefotaxime—Haemoglobin—Mesalazine—Crohn's disease	0.00249	0.00857	CcSEcCtD
Cefotaxime—Haemorrhage—Mesalazine—Crohn's disease	0.00248	0.00853	CcSEcCtD
Cefotaxime—Hepatitis—Mesalazine—Crohn's disease	0.00248	0.00853	CcSEcCtD
Cefotaxime—Arrhythmia—Azathioprine—Crohn's disease	0.00243	0.00837	CcSEcCtD
Cefotaxime—Cefradine—SLC22A5—Crohn's disease	0.00241	0.0823	CrCbGaD
Cefotaxime—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00239	0.00823	CcSEcCtD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00236	0.0118	CbGpPWpGaD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00236	0.0118	CbGpPWpGaD
Cefotaxime—Erythema multiforme—Mesalazine—Crohn's disease	0.00235	0.00806	CcSEcCtD
Cefotaxime—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00231	0.0115	CbGpPWpGaD
Cefotaxime—Cefadroxil—SLC22A5—Crohn's disease	0.00228	0.0779	CrCbGaD
Cefotaxime—Diarrhoea—Mercaptopurine—Crohn's disease	0.00222	0.00764	CcSEcCtD
Cefotaxime—Ill-defined disorder—Azathioprine—Crohn's disease	0.0022	0.00756	CcSEcCtD
Cefotaxime—Malaise—Azathioprine—Crohn's disease	0.00214	0.00735	CcSEcCtD
Cefotaxime—Leukopenia—Azathioprine—Crohn's disease	0.00212	0.0073	CcSEcCtD
Cefotaxime—Cefdinir—MPO—Crohn's disease	0.00211	0.072	CrCbGaD
Cefotaxime—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.0021	0.0105	CbGpPWpGaD
Cefotaxime—Cefaclor—MPO—Crohn's disease	0.00209	0.0713	CrCbGaD
Cefotaxime—Vomiting—Mercaptopurine—Crohn's disease	0.00207	0.0071	CcSEcCtD
Cefotaxime—Rash—Mercaptopurine—Crohn's disease	0.00205	0.00704	CcSEcCtD
Cefotaxime—Dermatitis—Mercaptopurine—Crohn's disease	0.00205	0.00703	CcSEcCtD
Cefotaxime—Ill-defined disorder—Mesalazine—Crohn's disease	0.002	0.00689	CcSEcCtD
Cefotaxime—Discomfort—Azathioprine—Crohn's disease	0.00199	0.00686	CcSEcCtD
Cefotaxime—Angioedema—Mesalazine—Crohn's disease	0.00197	0.00678	CcSEcCtD
Cefotaxime—Malaise—Mesalazine—Crohn's disease	0.00195	0.0067	CcSEcCtD
Cefotaxime—Leukopenia—Mesalazine—Crohn's disease	0.00193	0.00665	CcSEcCtD
Cefotaxime—Nausea—Mercaptopurine—Crohn's disease	0.00193	0.00663	CcSEcCtD
Cefotaxime—Thrombocytopenia—Azathioprine—Crohn's disease	0.0019	0.00651	CcSEcCtD
Cefotaxime—Discomfort—Mesalazine—Crohn's disease	0.00182	0.00625	CcSEcCtD
Cefotaxime—Anaphylactic shock—Mesalazine—Crohn's disease	0.00176	0.00606	CcSEcCtD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00176	0.00879	CbGpPWpGaD
Cefotaxime—Shock—Mesalazine—Crohn's disease	0.00173	0.00596	CcSEcCtD
Cefotaxime—Thrombocytopenia—Mesalazine—Crohn's disease	0.00173	0.00593	CcSEcCtD
Cefotaxime—Cefalotin—SLC22A5—Crohn's disease	0.00172	0.0586	CrCbGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00168	0.00841	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00168	0.00841	CbGpPWpGaD
Cefotaxime—Feeling abnormal—Azathioprine—Crohn's disease	0.0016	0.00548	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00158	0.00544	CcSEcCtD
Cefotaxime—Cephalexin—SLC22A5—Crohn's disease	0.00156	0.0533	CrCbGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00156	0.00777	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00156	0.00777	CbGpPWpGaD
Cefotaxime—Neutropenia—Prednisone—Crohn's disease	0.00153	0.00527	CcSEcCtD
Cefotaxime—Abdominal pain—Azathioprine—Crohn's disease	0.00153	0.00526	CcSEcCtD
Cefotaxime—Body temperature increased—Azathioprine—Crohn's disease	0.00153	0.00526	CcSEcCtD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00153	0.00763	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00153	0.00763	CbGpPWpGaD
Cefotaxime—Pain—Mesalazine—Crohn's disease	0.00151	0.00518	CcSEcCtD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00147	0.00733	CbGpPWpGaD
Cefotaxime—Feeling abnormal—Mesalazine—Crohn's disease	0.00145	0.00499	CcSEcCtD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00144	0.00721	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00144	0.00721	CbGpPWpGaD
Cefotaxime—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00144	0.00496	CcSEcCtD
Cefotaxime—Hypersensitivity—Azathioprine—Crohn's disease	0.00143	0.0049	CcSEcCtD
Cefotaxime—Urticaria—Mesalazine—Crohn's disease	0.0014	0.00481	CcSEcCtD
Cefotaxime—Body temperature increased—Mesalazine—Crohn's disease	0.00139	0.00479	CcSEcCtD
Cefotaxime—Abdominal pain—Mesalazine—Crohn's disease	0.00139	0.00479	CcSEcCtD
Cefotaxime—Diarrhoea—Azathioprine—Crohn's disease	0.00132	0.00455	CcSEcCtD
Cefotaxime—Haemoglobin—Prednisone—Crohn's disease	0.00132	0.00454	CcSEcCtD
Cefotaxime—Haemorrhage—Prednisone—Crohn's disease	0.00131	0.00451	CcSEcCtD
Cefotaxime—Hypersensitivity—Mesalazine—Crohn's disease	0.0013	0.00446	CcSEcCtD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00129	0.00641	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00129	0.00641	CbGpPWpGaD
Cefotaxime—Pruritus—Mesalazine—Crohn's disease	0.00125	0.00429	CcSEcCtD
Cefotaxime—Vomiting—Azathioprine—Crohn's disease	0.00123	0.00423	CcSEcCtD
Cefotaxime—Rash—Azathioprine—Crohn's disease	0.00122	0.00419	CcSEcCtD
Cefotaxime—Dermatitis—Azathioprine—Crohn's disease	0.00122	0.00419	CcSEcCtD
Cefotaxime—Headache—Azathioprine—Crohn's disease	0.00121	0.00417	CcSEcCtD
Cefotaxime—Diarrhoea—Mesalazine—Crohn's disease	0.00121	0.00415	CcSEcCtD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00119	0.00592	CbGpPWpGaD
Cefotaxime—Arrhythmia—Prednisone—Crohn's disease	0.00117	0.00403	CcSEcCtD
Cefotaxime—Nausea—Azathioprine—Crohn's disease	0.00115	0.00395	CcSEcCtD
Cefotaxime—Vomiting—Mesalazine—Crohn's disease	0.00112	0.00385	CcSEcCtD
Cefotaxime—Rash—Mesalazine—Crohn's disease	0.00111	0.00382	CcSEcCtD
Cefotaxime—Dermatitis—Mesalazine—Crohn's disease	0.00111	0.00382	CcSEcCtD
Cefotaxime—Headache—Mesalazine—Crohn's disease	0.0011	0.0038	CcSEcCtD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.0011	0.00547	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00108	0.00537	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00107	0.00535	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00107	0.00535	CbGpPWpGaD
Cefotaxime—Ill-defined disorder—Prednisone—Crohn's disease	0.00106	0.00364	CcSEcCtD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00105	0.00523	CbGpPWpGaD
Cefotaxime—Nausea—Mesalazine—Crohn's disease	0.00105	0.0036	CcSEcCtD
Cefotaxime—Angioedema—Prednisone—Crohn's disease	0.00104	0.00359	CcSEcCtD
Cefotaxime—Malaise—Prednisone—Crohn's disease	0.00103	0.00354	CcSEcCtD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00102	0.00508	CbGpPWpGaD
Cefotaxime—Convulsion—Prednisone—Crohn's disease	0.00099	0.0034	CcSEcCtD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00097	0.00484	CbGpPWpGaD
Cefotaxime—Discomfort—Prednisone—Crohn's disease	0.000961	0.0033	CcSEcCtD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000952	0.00475	CbGpPWpGaD
Cefotaxime—Anaphylactic shock—Prednisone—Crohn's disease	0.000933	0.00321	CcSEcCtD
Cefotaxime—Shock—Prednisone—Crohn's disease	0.000918	0.00315	CcSEcCtD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000905	0.00452	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.0009	0.00449	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000856	0.00427	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000856	0.00427	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.0008	0.00399	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000791	0.00395	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000791	0.00395	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000777	0.00388	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000777	0.00388	CbGpPWpGaD
Cefotaxime—Feeling abnormal—Prednisone—Crohn's disease	0.000769	0.00264	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Prednisone—Crohn's disease	0.000763	0.00262	CcSEcCtD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000756	0.00377	CbGpPWpGaD
Cefotaxime—Urticaria—Prednisone—Crohn's disease	0.000741	0.00255	CcSEcCtD
Cefotaxime—Abdominal pain—Prednisone—Crohn's disease	0.000737	0.00253	CcSEcCtD
Cefotaxime—Body temperature increased—Prednisone—Crohn's disease	0.000737	0.00253	CcSEcCtD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000734	0.00366	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000734	0.00366	CbGpPWpGaD
Cefotaxime—Hypersensitivity—Prednisone—Crohn's disease	0.000687	0.00236	CcSEcCtD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000668	0.00333	CbGpPWpGaD
Cefotaxime—Pruritus—Prednisone—Crohn's disease	0.00066	0.00227	CcSEcCtD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000653	0.00326	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000653	0.00326	CbGpPWpGaD
Cefotaxime—Diarrhoea—Prednisone—Crohn's disease	0.000638	0.00219	CcSEcCtD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000603	0.00301	CbGpPWpGaD
Cefotaxime—Vomiting—Prednisone—Crohn's disease	0.000593	0.00204	CcSEcCtD
Cefotaxime—Rash—Prednisone—Crohn's disease	0.000588	0.00202	CcSEcCtD
Cefotaxime—Dermatitis—Prednisone—Crohn's disease	0.000588	0.00202	CcSEcCtD
Cefotaxime—Headache—Prednisone—Crohn's disease	0.000584	0.00201	CcSEcCtD
Cefotaxime—Cefazolin—ALB—Crohn's disease	0.000573	0.0196	CrCbGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000557	0.00278	CbGpPWpGaD
Cefotaxime—Nausea—Prednisone—Crohn's disease	0.000554	0.0019	CcSEcCtD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000547	0.00273	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000545	0.00272	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000545	0.00272	CbGpPWpGaD
Cefotaxime—Ceftriaxone—ALB—Crohn's disease	0.000543	0.0186	CrCbGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000533	0.00266	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000517	0.00258	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000493	0.00246	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000484	0.00241	CbGpPWpGaD
Cefotaxime—Cefalotin—ALB—Crohn's disease	0.000476	0.0163	CrCbGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00046	0.0023	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000457	0.00228	CbGpPWpGaD
Cefotaxime—Cephalexin—ALB—Crohn's disease	0.000433	0.0148	CrCbGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000407	0.00203	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000384	0.00192	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000378	0.00188	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000349	0.00174	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000343	0.00171	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000339	0.00169	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000324	0.00162	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000288	0.00144	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.00024	0.0012	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000192	0.000958	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000177	0.000885	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000174	0.000869	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000165	0.000821	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000146	0.00073	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000122	0.00061	CbGpPWpGaD
